The DOI matches its Crossref record; 166 of the 166 references it cites were found in a registry or an index.
Presynaptic antiseizure medications-basic mechanisms and clues for their rational combinations
Open accessAbstract
Among clinically highly efficient antiseizure medications (ASMs) there are modifiers of the presynaptic release machinery. Of them, levetiracetam and brivaracetam show a high affinity to the synaptic vesicle protein type 2 A (SV2A), whereas pregabalin and gabapentin are selective ligands for the α2δ1 subunits of the voltage-gated calcium channels. In this paper, we present recent progress in understanding the significance of presynaptic release machinery in the neurochemical mechanisms of epilepsy and ASMs. Furthermore, we discuss whether the knowledge of the basic mechanisms of the presynaptically acting ASMs might help establish a rational polytherapy for drug-resistant epilepsy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1 The main neuronal targets of racetams and gabapentinoids (inspired by the figure in the paper by Bialer and White [166])](https://figures.cochat.ai/paper-figures/214bd69aa7d24435a3fffecf5c6f060f/presynaptic-antiseizure-medications-basic-mechanisms-and-clues-for-their-figure-1.jpg)
![Fig. 2 Isobolograms illustrating interactions between gabapentin and pregabalin in the 6 Hz corneal stimulation-induced seizure (A) and maximal electroshock-induced (MES) seizure (B) tests in mice. A. The type I isobolographic analysis was used to assess the interactions between two fully effective drugs in the mouse 6 Hz test (A). The isobologram for the combination of two fully active drugs, pregabalin and gabapentin in the 6 Hz test was presented earlier [77], and partly modified to display isobolographically areas of synergy, additivity and antagonism, where the experimentally derived ED50 mix value can be placed. The ED50 values for pregabalin and gabapentin when used alone in the 6 Hz test are placed on the ordinate (Y) and abscissa (X) of the Cartesian plot system of coordinates, respectively. The line connecting these ED50 values on the X and Y axes is the line of additivity. The diagonal line starting from the beginning of the Cartesian plot system and crossing the line of additivity indicates the proportion of the two-drug mixture (at the fixed-ratio of 1:1). For the interaction of pregabalin with gabapentin in the 6 Hz test, the experimentally derived ED50 mix (as the point M on the graph) is placed in the area of additivity, close to the point A, which reflects the theoretically calculated ED50 add value, predicted to exert additive interaction between drugs. B. The type II isobolographic analysis was conducted to evaluate the interaction between drugs of which gabapentin was ineffective in the mouse MES test (B). The isobologram for the combination of pregabalin (a fully active drug) and gabapentin (a virtually ineffective drug) in the MES test was presented earlier [130], and partly modified to display isobolographically areas of synergy, additivity and antagonism, where the experimentally derived ED50 mix value can be placed. The ED50 value for pregabalin when used alone in the mouse MES test is placed on the ordinate of the Cartesian plot system of coordinates. The line parallel to X axis starting from the ED50 for pregabalin is the line of indifference (additivity). The diagonal lines starting from the beginning of the Cartesian plot system and crossing the line of additivity indicate the proportions of the drugs in the mixture (at the fixed-ratios of 1:1, 1:2 and 1:4). For the interaction of pregabalin with gabapentin in the MES test, the experimentally derived ED50 mix (as the point M on the graph for the fixed-ratio of 1:1) is placed in the area of synergy, significantly below the area of additivity (*p < 0.05), which reflects the theoretically calculated ED50 add value, predicted to exert additive interaction between drugs](https://figures.cochat.ai/paper-figures/ace3fa425a3d4a298f861b3fb78b7ba8/presynaptic-antiseizure-medications-basic-mechanisms-and-clues-for-their-figure-2.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Functionally, SV2A modulation limits the slide from induced plasticity to maladaptive remodeling and relapse-like behavior [175,199,205].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [205]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“After ketamine or other plasticity-promoting interventions, preserving vesicle cycling and maintaining a competent readily releasable pool appear crucial for sustaining gains; animal studies link antidepressant durability to synaptic integrity supported by SV2A pathways and complementary signaling through ERK and calcium channels [199,201,205].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [205]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“After ketamine or other plasticity-promoting interventions, preserving vesicle cycling and maintaining a competent readily releasable pool appear crucial for sustaining gains; animal studies link antidepressant durability to synaptic integrity supported by SV2A pathways and complementary signaling through ERK and calcium channels [199,201,205].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [205]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Conceptually, SV2A enhancers complement plasticity modulators by securing the presynaptic substrate needed to translate spine growth into durable circuit performance, a metaplasticity framework that aims to extend remission and minimize recurrence across neuropsychiatric disorders [205,226].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [205]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Levetiracetam analogs and newer SV2A enhancers are attractive maintenance-phase adjuncts because they directly stabilize presynaptic function after induction therapies [175,199,205].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [205]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thijs, R. D., Surges, R., O'Brien, T. J., & Sander, J. W. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32596-0 · Cited by 2,183
The synaptic vesicle cycle: a cascade of protein–protein interactions
Südhof, T. C. (1995) · Nature · doi:10.1038/375645a0 · Cited by 1,989 · cited 1×
“This hypothesis has been supported by electrophysiological studies which demonstrated that sv2a deletion reduces the action of the potential-dependent release of GABA in the CA3 region of SV cycle have been identified and their role partially unrav - eled [25 ].”
ResultSöllner, T., Bennett, M. K., Whiteheart, S. W., Scheller, R. H., & Rothman, J. E. (1993) · Cell · doi:10.1016/0092-8674(93)90376-2 · Cited by 1,896 · cited 1×
“Several synaptic proteins such as synapto-brevin, vesicle-associated SNARE (v-SNARE), and two target or plasma membrane SNAREs (t-SNAREs), synapto-somal associated protein 25 (SNAP25) and syntaxin form a stable complex that is probably engaged in both SV docking and fusion [26].”
BackgroundThe synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam
Lynch, B. A., Lambeng, N., Nocka, K., Kensel-Hammes, P., Bajjalieh, S. M., Matagne, A., & Fuks, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308208101 · Cited by 1,610 · cited 2×
“Lynch et al. (2004) first provided several lines of evidence that the synaptic vesicle protein SV2A was the binding site for levetiracetam ((S)-alpha- ethyl-2-oxo-pyrrolidine acetamide).”
BackgroundBerenbaum, M. C. (1989) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00026-2 · Cited by 1,414
Jasper's Basic Mechanisms of the Epilepsies
(2012) · Oxford University Press eBooks · doi:10.1093/med/9780199746545.001.0001 · Cited by 1,143
Neher, E. (1998) · Neuron · doi:10.1016/s0896-6273(00)80983-6 · Cited by 1,010
Marson, A. G., Al-Kharusi, A. M., Alwaidh, M., Appleton, R., Baker, G. A., Chadwick, D. W., Cramp, C., Cockerell, O. C., Cooper, P. N., Doughty, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60460-7 · Cited by 976 · cited 1×
“However, in a large comparative study, gabapentin was found to be less effective than lamotrigine [ 144].”
BackgroundLöscher, W. (2011) · Seizure · doi:10.1016/j.seizure.2011.01.003 · Cited by 932
Löscher, W., Potschka, H., Sisodiya, S. M., & Vezzani, A. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019539 · Cited by 903
Cited by
The neuroplastic brain: current breakthroughs and emerging frontiers
Gazerani, P. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149643 · Cited by 174
“…2022; Jannati et al., 2023; Suppa et al., 2022; Lefaucheur et al., 2020). o Transcranial Direct Current Stimulation (tDCS): tDCS can induce long-term changes in neuronal excitability (Lang et al., 2004), facilitating motor and cognitive recovery in stroke and neuropsychiatric disorders…”
Plants, Pills, and the Brain: Exploring Phytochemicals and Neurological Medicines
Aggarwal, A., Rajalekshmi, R., Aggarwal, A., & Agrawal, D. K. (2025) · International Journal of Plant Animal and Environmental Sciences · doi:10.26502/ijpaes.4490180 · Cited by 8
“Levetiracetam’s precise binding to SV2A facilitates broad-spectrum seizure control with minimal drug-drug interactions, making it a preferred option for both monotherapy and adjunctive use [43,44].”
Epilepsy: Epidemiology, Molecular Pathogenesis, and Clinical Management
Liu, J., Wu, X., Yin, T., Huang, F., Kong, M., Yang, Y., Liu, Z. H., Yu, J., & Zhang, T. (2026) · MedComm · doi:10.1002/mco2.70837 · Cited by 5
Supportive pain therapy in dermatology
Werner, M., Stromer, W., Hüning, S., Loquai, C., Kähler, K. C., Susok, L., & Nashan, D. (2025) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.15624 · Cited by 1
Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery
Tanaka, M. (2026) · Biomedicines · doi:10.3390/biomedicines14061265
Metadata
- Authors
- Czapińska-Ciepiela, E. K., Łuszczki, J., Czapiński, P., Czuczwar, S. J., & Lasoń, W.
- Affiliations
- Medical University of Lublin (PL)
- Maj Institute of Pharmacology (PL)
- Corresponding author
- Lasoń, Władysław
- Venue
- Pharmacological Reports
- Published
- 2024-05-22
- Volume
- 76
- Issue
- 4
- Pages
- 623-643
- ISSN
- 1734-1140 (ISSN-L)
- 2299-5684
- PMC
- PMC11294404
- OpenAlex
- W4398219983
- Cited by
- 13
- References
- 166
- Citations by year
- 2026: 10 · 2025: 3
- FWCI
- 1.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Pharmacological Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Keywords
- levetiracetam, brivaracetam, pregabalin, gabapentin, α2δ-1 subunit, voltage-gated calcium channels, epilepsy, drug-resistant epilepsy, combination therapy
- MeSH terms
- Animals, Anticonvulsants, Epilepsy, Humans, Calcium Channels, Presynaptic Terminals
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Presynaptic antiseizure medications-basic mechanisms and clues for their rational combinations. https://app.cochat.ai/papers/10.1007/s43440-024-00603-7
- The paper
- Czapińska-Ciepiela, E. K., Łuszczki, J., Czapiński, P., Czuczwar, S. J., & Lasoń, W. (2024). Presynaptic antiseizure medications-basic mechanisms and clues for their rational combinations. Pharmacological Reports. https://doi.org/10.1007/s43440-024-00603-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.